Ceragenix Pharmaceuticals

Research on Use of Ceragenins(TM) As Potential Therapy for Cystic
dBusinessNews.com - DENVER -- Interscience Conference on Antimicrobial Agents and Chemotherapy(ICAAC) Ceragenix Pharmaceuticals, Inc. a biopharmaceutical company focused on infectious disease and dermatology, today announced that the American Society of Microbiology

Innovations & ideas, 7/2
Denver Post - A Denver-based biotechnology company is looking at ways to treat eczema in children without using steroids. Ceragenix Pharmaceuticals Inc. said last week that it will begin a study of its topical cream Epiceram to see if it works just as well on

Chemical to block HIV infection identified
Onlypunjab.com - The chemical was developed by scientists at Brigham Young University, Utah, and is licensed to a company called Ceragenix Pharmaceuticals. Brigham Young University and Vanderbilt have jointly filed a patent on the compounds, the report said. US

Research on Use of Ceragenins(TM) as Potential Therapy for Behcet's
Genetic Engineering News - Ceragenix Pharmaceuticals, Inc., a biopharmaceutical company focused on infectious disease and dermatology, today announced that research by Dr. Emiko Isogai of the University of Hokkaido's School of Dentistry describing in vitro efficacy of a

Colorado business, 7/27
Denver Post - Ceragenix Pharmaceuticals Inc. , a Denver-based biopharmaceutical

Smoking in Pregnancy May Cause Behavioral Troubles in Offspring
KRNV - NEW YORK, July 13 /PRNewswire-FirstCall/ -- On July 12, Steven Porter, CEO of Ceragenix Pharmaceuticals, Inc. updated the investment community in an exclusive interview with www.wallst.net . Topics covered in the interview include an overview of the